Dr. Agarwal’s Health Care Limited announced robust H1 FY26 results, achieving a 20.2% year-on-year increase in total income to INR 1,007 crores. PAT reached an all-time high of INR 75 crores, up 88.4% year-on-year. The company served over 14.3 lakh patients and performed approximately 157,000 surgeries through its network of 258 facilities. Expansion plans include adding 30 new facilities in the next two quarters.
Financial Performance Highlights
Dr. Agarwal’s Health Care Limited reported strong financial results for H1 FY26, demonstrating significant growth across key metrics:
- Total income increased by 20.2% year-on-year, reaching INR 1,007 crores.
- Revenue from operations rose by 20.2% to INR 986 crores.
- IndAS EBITDA grew by 24.9% year-on-year to INR 285 crores, with margins improving to 28.3%.
- PAT grew by 88.4% year-on-year to INR 75 crores, with margins expanding to 7.2%.
Network Expansion and Surgical Performance
The company continues to expand its network and enhance its surgical capabilities:
- Served over 14.3 lakh patients and performed nearly 157,000 surgeries.
- Network comprises 258 facilities, including 29 hubs and 229 spokes across 14 states and 5 union territories.
- Commissioned 24 new Greenfield facilities.
- High-end cataract surgeries accounted for 25.8% of total cataract procedures, totaling 29,697 surgeries, up by 41.7% year-on-year.
- Robotic cataract surgeries grew by 69% year-on-year.
- Lenticular (SMILE) surgeries increased by 11.5% year-on-year.
- Retinal surgeries totaled 6,205 in H1, up by 23% from last year.
Regional Performance
The Southern region remains the largest market, contributing 64% of group revenues with INR 635 crores, a 22.2% year-on-year growth. The West region contributed 15.2% with INR 150 crores, up 16.6% year-on-year. The North region reported INR 72 crores, up 14.2% year-on-year, while same-store sales growth increased by 13.4%.
Future Outlook
The company plans to launch another 30 facilities in the next two quarters and expects continued growth driven by operational efficiencies and strategic expansions. Focus remains on increasing adoption of advanced technologies and strengthening market presence in key regions.
Source: BSE